We are a clinical diagnostic company pioneering a new field of personalized diagnostics based on nuclear magnetic resonance, or NMR, technology. Our first diagnostic test, the NMR LipoProfile® test, directly measures the number of low density lipoprotein, or LDL, particles, also known as LDL-P, in a blood sample and provides physicians and their patients with actionable information to personalize management of risk for heart disease. To date, over 11 million NMR LipoProfile tests have been ordered including nearly 2 million during 2012 and 2.1 million during 2013. Our strategy is to continue to advance patient care by converting clinicians, and the clinical diagnostic laboratories they use, from traditional cholesterol testing to our NMR LipoProfile test for the management of patients at risk for cardiovascular disease, with the goal of ultimately becoming the preferred choice by physicians for the management of patients with cardiovascular disease. A number of large clinical outcome studies including the Multi-Ethnic Study of Atherosclerosis, or MESA, and the Framingham Offspring Study, indicate that a patient's number of LDL particles is more strongly associated with the risk of developing cardiovascular disease than is his or her level of LDL cholesterol (LDL-C) when one of the measures suggests a higher risk and the other suggests a lower risk.
Company profile
Ticker
LPDX
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
IRS number
561879288
Latest filings (excl ownership)
15-12B
Securities registration termination
2 Dec 14
EFFECT
Notice of effectiveness
26 Nov 14
8-K/A
Amendments to Articles of Incorporation or Bylaws
25 Nov 14
POS AM
Prospectus update (post-effective amendment)
24 Nov 14
S-8 POS
Registration of securities for employees (post-effective amendment)
24 Nov 14
S-8 POS
Registration of securities for employees (post-effective amendment)
24 Nov 14
25-NSE
Exchange delisting
21 Nov 14
8-K
Labcorp Completes Acquisition of Liposcience
21 Nov 14
10-Q
2014 Q3
Quarterly report
12 Nov 14
8-K
LipoScience Announces 2014 Third Quarter Financial Results
12 Nov 14
Latest ownership filings
SC 13G/A
Liposcience Inc
17 Feb 15
SC 13G/A
Liposcience Inc
17 Feb 15
SC 13G/A
Liposcience Inc
12 Feb 15
SC 13G
Liposcience Inc
12 Feb 15
SC 13D/A
Liposcience Inc
24 Nov 14
SC 13G
Liposcience Inc
10 Nov 14
SC 13D
Liposcience Inc
3 Oct 14
SC 13G
Liposcience Inc
20 Mar 14
SC 13G
Liposcience Inc
20 Feb 14
SC 13G/A
Liposcience Inc
14 Feb 14